Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$162,214,524
-$21,643,895 QoQ
Shares Held
22,911,656
-0.1% QoQ
Ownership
3.37%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. GRFS ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
|
5,205,926 | $249,572,092 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162,214,524 | 22,911,656 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $183,858,419 | 22,924,990 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $214,348,656 | 22,924,990 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $228,344,354 | 22,926,140 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $195,740,850 | 21,652,749 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $153,023,097 | 21,522,236 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $157,238,671 | 21,134,230 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $186,301,263 | 20,979,872 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $131,813,615 | 20,889,638 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $138,604,823 | 20,749,225 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $228,743,789 | 19,787,525 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $179,409,526 | 19,629,051 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $178,764,324 | 19,515,756 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $143,068,732 | 19,412,311 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $164,892,392 | 19,399,105 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $110,073,206 | 17,869,027 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $203,499,588 | 17,129,595 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $200,570,630 | 17,172,143 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $167,407,159 | 14,907,138 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $189,564,969 | 12,975,015 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $233,517,866 | 13,459,243 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $231,177,293 | 13,370,578 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $213,777,667 | 11,593,149 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $185,213,401 | 10,675,124 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,243,136 | 616,400 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,414,296 | 616,400 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||